BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹236 Cr | ₹172 Cr | ₹157 Cr | ₹193 Cr | ₹233 Cr |
What is the latest Total Current Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹236 Cr |
| Mar2025 | ₹172 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹193 Cr |
| Mar2022 | ₹233 Cr |
How is Total Current Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹236 Cr | 36.81 | |
| Mar2025 | ₹172 Cr | 9.38 | |
| Mar2024 | ₹157 Cr | -18.55 | |
| Mar2023 | ₹193 Cr | -17.09 | |
| Mar2022 | ₹233 Cr | - | |
Compare Total Current Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹7,273.0 Cr | -3.5% | 8.7% | 370.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -3.5% |
8.7% |
370.2% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses